Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Fernando Munayco-Guillén, Miguel Angel Vazquez-Membrillo, Marlon Rafael Garcia-Roa, Jhony Alberto De La Cruz-Vargas, Herney Andrés García-Perdomo & Rafael Pichardo-Rodriguez. (2023) Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting. Clinical Ophthalmology 17, pages 1129-1135.
Read now
Read now
Moein Ebrahimi, Maryam Balibegloo & Nima Rezaei. (2022) Monoclonal antibodies in diabetic retinopathy. Expert Review of Clinical Immunology 18:2, pages 163-178.
Read now
Read now
Daniele Veritti, Valentina Sarao, Valentina Soppelsa & Paolo Lanzetta. (2021) Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options. Clinical Ophthalmology 15, pages 375-385.
Read now
Read now
Esra Türkseven Kumral & Nimet Yeşim Erçalık. (2021) Intravitreal Ranibizumab Versus Aflibercept for Diabetic Macular Edema in Vitrectomized Eyes: 12 Month Results. Seminars in Ophthalmology 36:8, pages 723-727.
Read now
Read now
Havva Kaldırım, Serpil Yazgan, Ahmet Kırgız, Kursat Atalay & Fatma Savur. (2019) A Comparison Study of Ranibizumab and Aflibercept in Patients with Naive Diabetic Macular Edema in Presence of Serous Retinal Detachment. Current Eye Research 44:9, pages 987-993.
Read now
Read now
Rafael Campos Polo, Consuelo Rubio Sánchez, Diego Manuel García Guisado & María José Díaz Luque. (2018) Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice. Clinical Ophthalmology 12, pages 99-104.
Read now
Read now
Mihaela Popescu, Cătălina Bogdan, Adela Pintea, Dumitriţa Rugină & Corina Ionescu. (2018) Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy. Drug Design, Development and Therapy 12, pages 1985-1996.
Read now
Read now
Magdalena Edington, Julie Connolly & Ngaihang Victor Chong. (2017) Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes. Expert Opinion on Drug Metabolism & Toxicology 13:12, pages 1217-1224.
Read now
Read now
Articles from other publishers (17)
Xiao Xie, Chao Lian, Zhiping Zhang, Meng Feng, Wenqi Wang, Xiaomeng Yuan, Yanmei Shi & Tingting Liu. (2023) Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis. Frontiers in Endocrinology 14.
Crossref
Crossref
Patrick Wang, Zoe Hu, Maggie Hou, Patrick A. Norman, Eric K. Chin & David RP Almeida. (2022) Relationship Between Macular Thickness and Visual Acuity in the Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic Review. Journal of VitreoRetinal Diseases 7:1, pages 57-64.
Crossref
Crossref
Amin E. Nawar, Tamer Wasfy & Heba M. Shafik. (2022) Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection. BMC Ophthalmology 22:1.
Crossref
Crossref
Kübra Özata Gündoğdu, Emine Doğan, Erkan Çelik & Gürsoy Alagöz. (2022) Effect of intravitreal ranibizumab on serous retinal detachment in diabetic macular edema. Journal of Diabetes and its Complications 36:7, pages 108228.
Crossref
Crossref
Sangeetha Santhakumaran, Ali Salimi, VanessaC Brunetti & John Galic. (2022) Efficacy and safety of aflibercept therapy for diabetic macular edema: A systematic review and meta-analysis. Journal of Current Ophthalmology 34:2, pages 133.
Crossref
Crossref
Xuexue Zhang, Yi Liu, Miaoran Wang, Qiuyan Li, Wantong Zhang, Rui Zhang & Yufei Wu. (2021) Efficacy of Antiangiogenic Drugs in the Treatment of Diabetic Macular Edema: A Bayesian Network Analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
Chu-Hsuan Huang, Chang-Hao Yang, Yi-Ting Hsieh, Chung-May Yang, Tzyy-Chang Ho & Tso-Ting Lai. (2021) Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy. Scientific Reports 11:1.
Crossref
Crossref
Ahmet EKİZOĞLU & Murat ÇAKMAKLIOĞULLARI. (2021) Comparison of the efficacy of aflibercept and ranibizumab after a 3-month loading dose in patients with diabetic macular edema. Journal of Surgery and Medicine 5:3, pages 299-302.
Crossref
Crossref
B. Holbach, F. Zeman, H. Helbig & M. A. Gamulescu. (2019) Ranibizumab und Aflibercept bei diabetischem Makulaödem – Retrospektive Studie mit Ergebnissen aus dem klinischen Alltag nach 12 MonatenRanibizumab and aflibercept for diabetic macular edema—retrospective study with real-life data after 12 months. Der Ophthalmologe 117:7, pages 687-692.
Crossref
Crossref
Abdullah Ozkaya, Gokhan Demir & Asli Kirmaci. (2019) Comparison of aflibercept and ranibizumab in diabetic macular edema associated with subretinal detachment. European Journal of Ophthalmology 30:2, pages 363-369.
Crossref
Crossref
Pablo Plaza-Ramos, Enrique Borque & Alfredo García-Layana. (2019) Evaluation of ranibizumab and aflibercept for the treatment of diabetic macular edema in daily clinical practice. PLOS ONE 14:10, pages e0223793.
Crossref
Crossref
Abeer M. Khattab, Sherein M. Hagras, AhmedHosni AbdElhamid, Magda A. Torky, Eman A. Awad & Ameera G. Abdelhameed. (2019) Aflibercept with adjuvant micropulsed yellow laser versus aflibercept monotherapy in diabetic macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology 257:7, pages 1373-1380.
Crossref
Crossref
Ba' Pham, Sonia M Thomas, Erin Lillie, Taehoon Lee, Jemila Hamid, Trevor Richter, Ghayath Janoudi, Arnav Agarwal, Jane P Sharpe, Alistair Scott, Rachel Warren, Ronak Brahmbhatt, Erin Macdonald, Sharon E Straus & Andrea C Tricco. (2019) Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis. BMJ Open 9:5, pages e022031.
Crossref
Crossref
Jianshu Yuan. (2019) Role of inflammatory factors in the effects of aflibercept or ranibizumab treatment for alleviating wet age‑associated macular degeneration. Experimental and Therapeutic Medicine.
Crossref
Crossref
Hajin TchoeSang Jin ShinJae Kyung SuhSonghee ChoJangmi YangMin Joo KangDonghyun Jee. (2019) Meta-analysis of Intravitreal Injection of Anti-vascular Endothelial Growth Factors for Diabetic Macular Edema. Journal of the Korean Ophthalmological Society 60:2, pages 144.
Crossref
Crossref
Gianni Virgili, Mariacristina Parravano, Jennifer R Evans, Iris Gordon & Ersilia Lucenteforte. (2018) Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Cochrane Database of Systematic Reviews 2018:10.
Crossref
Crossref
Gianni Virgili, Mariacristina Parravano, Jennifer R Evans, Iris Gordon & Ersilia Lucenteforte. (2017) Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Crossref